Universität zu Köln

2020

Oberbeck, S., Schrader, A., Warner, K., Jungherz, D., Crispatzu, G., von Jan, J., Chmielewski, M., Ianevski, A., Diebner, H. H., Mayer, P., Ados, A. Kondo, Wahnschaffe, L., Braun, T., Mueller, T. A., Wagle, P., Bouska, A., Neumann, T., Puetzer, S., Varghese, L., Pflug, N., Thelen, M., Makalowski, J., Riet, N., Goex, H. J. M., Rappl, G., Altmueller, J., Kotrova, M., Persigehl, T., Hopfinger, G., Hansmann, M. L., Schloesser, H., Stilgenbauer, S., Duerig, J., Mougiakakos, D., Von Bergwelt-Baildon, M., Roeder, I, Hartmann, S., Hallek, M., Moriggl, R., Brueggemann, M., Aittokallio, T., Iqbal, J., Newrzela, S., Abken, H. and Herling, M. (2020). Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling. Blood, 136 (24). S. 2786 - 2803. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Puetzer, S., Varghese, L., von Jan, J., Braun, T., Giri, A. K., Mayer, P., Riet, N., Timonen, S., Oberbeck, S., Kuusanmaki, H., Mustjoki, S., Stern, M. -H., Aittokallio, T., Newrzela, S., Schrader, A. and Herling, M. (2020). Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine. Leukemia, 34 (9). S. 2513 - 2519. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

2018

Schrader, A., Crispatzu, G., Oberbeck, S., Mayer, P., Putzer, S., von Jan, J., Vasyutina, E., Warner, K., Weit, N., Pflug, N., Braun, T., Andersson, E. I., Yadav, B., Riabinska, A., Maurer, B., Ferreira, M. S. Ventura, Beier, F., Altmueller, J., Lanasa, M., Herling, C. D., Haferlach, T., Stilgenbauer, S., Hopfinger, G., Peifer, M., Bruemmendorf, T. H., Nuernberg, P., Elenitoba-Johnson, K. S. J., Zha, S., Hallek, M., Moriggl, R., Reinhardt, H. C., Stern, M. -H., Mustjoki, S., Newrzela, S., Frommolt, P. and Herling, M. (2018). Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL. Nat. Commun., 9. LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

2017

Kotrova, M., Novakova, M., Oberbeck, S., Mayer, P., Schrader, A., Knecht, H., Herling, M. and Brueggemann, M. (2017). VB EXPRESSION ASSESSMENT AND CLONALITY DETECTION IN T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) BY FLOW CYTOMETRY (FCM) AND NEXT GENERATION SEQUENCING (NGS): A COMPARISON OF BOTH METHODS. Haematologica, 102. S. 565 - 567. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Lohmann, G., Vasyutina, E., Bloehdorn, J., Reinart, N., Schneider, J. I., Babu, V., Knittel, G., Crispatzu, G., Mayer, P., Prinz, C., Muenzner, J. K., Biersack, B., Efremov, D. G., Chessa, L., Herling, C. D., Stilgenbauer, S., Hallek, M., Schobert, R., Reinhardt, H. C., Schumacher, B. and Herling, M. (2017). Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia. Leukemia, 31 (5). S. 1177 - 1187. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

2016

Spinner, S., Crispatzu, G., Yi, J-H, Munkhbaatar, E., Mayer, P., Hoeckendorf, U., Mueller, N., Li, Z., Schader, T., Bendz, H., Hartmann, S., Yabal, M., Pechloff, K., Heikenwalder, M., Kelly, G. L., Strasser, A., Peschel, C., Hansmann, M-L, Ruland, J., Keller, U., Newrzela, S., Herling, M. and Jost, P. J. (2016). Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance. Leukemia, 30 (7). S. 1520 - 1531. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

2015

Vasyutina, E., Boucas, J. M., Bloehdorn, J., Aszyk, C., Crispatzu, G., Stiefelhagen, M., Breuer, A., Mayer, P., Lengerke, C., Doehner, H., Beutner, D., Rosenwald, A., Stilgenbauer, S., Hallek, M., Benner, A. and Herling, M. (2015). The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL. Leukemia, 29 (10). S. 2003 - 2015. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551